Hyaluronidase Injection, Solution
Product Images NDC 51662-1555

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hyaluronidase (NDC 51662-1555). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box Label (51662 1555 1 Box Label)

The packaging label is for Hylenex recombinant 1 mL injection, containing hyaluronidase human injection at a strength of 150 USP units/mL. The label indicates it is a single dose vial, not for IV use, and requires refrigeration. The product is by Halozyme Therapeutics and displays NDC 18657-117-02.*

FDA Label Image

Serialized Labeling (51662 1555 1 Serialized Box Labeling)

Packaging label of Hylenex recombinant injection, 1 mL single dose vial with 150 USP units/mL of hyaluronidase human injection. The label includes the NDC 18657-117-02 and mentions the product is distributed by HF Acquisition Co LLC in Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.